Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02554110 · ClinicalTrials.gov registry record · NA
Peripheral Nerve Stimulation to Reduce Hypoxic Events
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT02554110: Completed NA study, sponsored by Mayo Clinic.
NCT02554110 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02554110, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
This study is designed to determine if using peripheral nerve stimulation in conjunction with pulse oximetry as an adjunct to traditional monitoring in the PACU reduces the frequency and severity of sedation related apnea and hypoxic events.
Interventions
- DEVICE Stimulator active device
- DEVICE Stimulator sham Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2015-10-12 |
| Est. Completion | 2017-01-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02554110
The ClinicalTrials.gov registry entry for NCT02554110 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stimulator active device is the first listed.
NCT02554110 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02554110 about?
NCT02554110 is a clinical study titled "Peripheral Nerve Stimulation to Reduce Hypoxic Events". This study is designed to determine if using peripheral nerve stimulation in conjunction with pulse oximetry as an adjunct to traditional monitoring in the PACU reduces the frequency and severity of sedation related apnea and hypoxic events.
What is the current status of trial NCT02554110?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2015-10-12. Estimated completion is 2017-01-19.
What interventions are being tested in trial NCT02554110?
The interventions under investigation include: Stimulator active device (DEVICE), Stimulator sham Device (DEVICE).
Who is sponsoring clinical trial NCT02554110?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.